The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma-Reference-Cited by-同舟云学术

The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma

Published:2016-11-14 Issue:1 Volume:16 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Sato Yuki,Fujimoto Daichi,Uehara Keiichiro,Shimizu Ryoko,Ito Jiro,Kogo Mariko,Teraoka Shunsuke,Kato Ryoji,Nagata Kazuma,Nakagawa Atsushi,Otsuka Kojiro,Hamakawa Hiroshi,Takahashi Yutaka,Imai Yukihiro,Tomii Keisuke

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-016-2897-6.pdf

Reference39 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.

2. Malvezzi M, Bertuccio P, Rosso T, Rota M, Levi F, La Vecchia C, Negri E. European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women? Ann Oncol. 2015;26(4):779–86.

3. Sturgeon C. Practice guidelines for tumor marker use in the clinic. Clin Chem. 2002;48(8):1151–9.

4. Ono A, Takahashi T, Mori K, Akamatsu H, Shukuya T, Taira T, Kenmotsu H, Naito T, Murakami H, Nakajima T, et al. Prognostic impact of serum CYFRA 21-1 in patients with advanced lung adenocarcinoma: a retrospective study. BMC Cancer. 2013;13:354.

5. Barlesi F, Gimenez C, Torre JP, Doddoli C, Mancini J, Greillier L, Roux F, Kleisbauer JP. Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer. Respir Med. 2004;98(4):357–62.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mass spectrometry analysis of intact protein N-glycosylation signatures of cells and sera in pancreatic adenocarcinomas;Journal of Zhejiang University-SCIENCE B;2024-01

2. Exploring the Role of Biomarkers Associated with Alveolar Damage and Dysfunction in Idiopathic Pulmonary Fibrosis—A Systematic Review;Journal of Personalized Medicine;2023-11-14

3. Prognostic value of blood-based protein biomarkers in non-small cell lung cancer: A critical review and 2008–2022 update;Tumor Biology;2023-10-28

4. Combined use of CYFRA 21-1 and CA 125 predicts survival of patients with metastatic NSCLC and stable disease in IMpower150;Tumor Biology;2023-08-02

5. Primary hepatoid adenocarcinoma of lung: A rare malignancy mimicking tuberculosis;Lung India;2023